Evidence map›Paper›PMID 37885364›Full record

ArticlePharmacology research & perspectives2023

Experimental pharmacology in precision medicine.

Alicja Urbaniak, Kenneth E Thummel, Ayoade N Alade, Allan E Rettie, Bhagwat Prasad, Amedeo De Nicolò, Jennifer H Martin, David N Sheppard, Michael F Jarvis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmacology research & perspectives, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Experimental pharmacology in precision medicine.Pharmacology research & perspectives · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alicja UrbaniakDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.ORCID 0000-0002-0807-1263
Kenneth E ThummelSchool of Pharmacy, University of Washington, Seattle, Washington, USA.
Ayoade N AladeSchool of Pharmacy, University of Washington, Seattle, Washington, USA.
Allan E RettieSchool of Pharmacy, University of Washington, Seattle, Washington, USA.
Bhagwat PrasadDepartment of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA.ORCID 0000-0002-9090-0912
Amedeo De NicolòUniversity of Turin, Turin, Italy.ORCID 0000-0002-5973-9948
Jennifer H MartinThe University of Newcastle Hunter Medical Research Institute, New Lambton, New South Wales, Australia.ORCID 0000-0002-8614-0199
David N SheppardSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.ORCID 0000-0001-5533-9130
Michael F JarvisPharmaceutical Sciences, University of Illinois-Chicago, Chicago, Illinois, USA.ORCID 0000-0001-9558-8203

Funding

Vitamin K gene network: Variant discovery and characterizationP01GM116691 · NIGMS · UNIVERSITY OF WASHINGTON · PI BURKE, WYLIE G. · 2016 to 2020
$7.6M
PBPK prediction of ontogeny mediated alteration in hepatic drug eliminationR01HD081299 · NICHD · WASHINGTON STATE UNIVERSITY · PI PRASAD, BHAGWAT · 2015 to 2025
$4.6M
Institutional Career DevelopmentKL2TR003108 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI ARTHUR, JOHN M., BORSHEIM, ELISABET · 2019 to 2023
$2.3M
Medical Research Council MR/S00274X/1NCATS NIH HHS KL2 TR003108NICHD NIH HHS R01 HD081299NIGMS NIH HHS P01 GM116691
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PharmacogeneticsPrecision MedicineDrug Discovery

Identifiers

PMID37885364
PMCPMC10603287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.